This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Chris Warner, PhD
Associate Director, Analytical Development at Primrose Bio


Chris Warner, PhD currently serves as the Associate Director of the Analytical Development Group at Primrose Bio. He is responsible for leading analytical development, detailed protein product characterization and providing regulatory CMC to support internal and partnered programs. Prior to being a member of the Primrose Bio team, Dr. Warner held positions with Boehringer-Ingelheim and Synthetic Genomics providing analytical support in the development of antibody therapeutics. Dr. Warner has authored and contributed to multiple publications, presentations, global regulatory filings, and patents and holds a PhD from the University of Sheffield in the United Kingdom.

Agenda Sessions

  • Efficient Therapeutic Development Using The Pfenex Expression Technology® Platform